AuditLine › HHS OIG › Centers for Medicare and Medicaid Services
HHS OIG recommendation 23-E-03-007.01
CMS should build a strategy to strengthen its internal controls for ensuring the accuracy of Part B drug payments.
The recommendation, in the publisher's words
CMS should build a strategy to strengthen its internal controls for ensuring the accuracy of Part B drug payments.
- Responsible agency
- Centers for Medicare and Medicaid Services
- Issued
- December 22, 2022
- Report
- CMS Should Bolster Its Oversight of Manufacturer-Submitted Average Sales Price Data To Ensure Accurate Part B Drug Payments (OEI-03-21-00390) · find it at HHS OIG
- Kind of report
- Evaluation
- Agency response
- Concur (as recorded by the publisher)
- Closed
- June 10, 2024 (publisher's date)
- Publisher topics
- Departmental Operational Issues, Financial Stewardship, Prescription Drug
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Implemented”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.